Loading, please wait ...


News Analytics

.
In 2015, Pfizer Inc. opted not to file an NDA for a 10mg OTC version of its cholesterol treatment Lipitor (atorvastatin) dor reasons similar to FDA’s reasons for rejecting Merck & Co.’s lovastatin switch proposals – concerns over whether consumers would accurately self-select and safely use the products (Also see "FDA Advisors Say Greater Insight Needed On Self-Selection Of OTC Statins" ...
Google

Subject Matter

  • Science and technology 53.70%
  • Healthcare 46.30%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions